User talk:Fghostyun6

您好，Fghostyun6！欢迎加入维基百科！

感謝您對維基百科的興趣與貢獻，希望您會喜歡這裡。除了歡迎辭以外，也請您了解以下重要文章：

政策 五大支柱 百科、中立、开放、互重、勇於创新	GNU 版權問題解答 貢獻內容必须是您所著或獲得授權、 并同意在CC-by-sa-3.0和GFDL條款下發布	手冊 使用指南 安全访问 / 測試編輯 / 如何编辑 使用手册 / 繁简处理 / 寫個好條目
問號 有问题？請到互助客栈询问，或在我的对话页提出。别忘記：討論後要簽名，方式之一是留下4個波浪紋「 ~~~~ 」。 If you have any questions about the Chinese Wikipedia, please leave a message here. Thank you for visiting!

• 閱讀新手应该注意的七种常见错误、理解維基百科的立場與常見注意事項。
• 有任何编辑上的问题？请试试IRC即时讨论。也可在下面加入「{{Helpme}}」，其他维基人见到后就会来提供帮助。
• 不知道有甚麼可写？条目请求、最多语言版本的待撰条目、缺少的传统百科全书条目和首页的缺失条目中列出了许多维基百科目前还没有的条目，欢迎您来撰寫！
• 希望您能享受共同编写百科的樂趣，成为一名充實的维基百科人。

我是欢迎您的维基人：飛ඣ 2011年7月4日 (一) 10:23 (UTC)(via Alexbot Operate via Alexsh)

您創建的條目User:Fghostyun6可能侵犯版權

您创建的条目被认为同他人的文字雷同，快去看看怎么回事。

维基百科只接受公有领域或知识共享 署名-相同方式共享 3.0协议的内容，如果希望文字内容继续留存在维基百科上，请：

• 捐献版权 - 适用于文字原创者或版权持有者；
• 请求版权许可 - 适用于复制他人内容，且希望继续使用者；
• 重写 - 适用于复制他人内容，且无法获得授权者；
• 申诉 - 这可能只是个误会。

谢谢您的合作。—Symplectopedia (留言) 2011年7月5日 (二) 09:21 (UTC)

膀胱癌肿瘤标志物检测试剂盒Urinary Bladder Neoplasms Molecular Marker Detection Kit

膀胱癌肿瘤分子标志物检测试剂盒 Urinary Bladder Neoplasms Molecular Marker Detection Kit

[Source: http://www.biopharmsoft.com]

Description: The kit provides a means of performing Urinary Bladder Neoplasms detection method based on kinase activity assay. This kit includes Streptavidin Coated Plates and specific SubstratePeptides (biotinylated peptide substrates) for detection of the activity of EGFR, FGFR3 and SRC which indicate the prognosis of Urinary Bladder Neoplasms.

Label of Substrate-Peptides: Biotinylated.

Quality Control: The substrate peptide was selected using our Urinary Bladder Neoplasms Diagnosis Kit. The quality of the biotinylated peptide was evaluated by reverse-phase HPLC and by mass spectrometry.

Storage:

Store at 4 °C, Avoid Freeze.

Background:

EGFR (epidermal growth factor receptor) exists on the cell surface and is activated by binding of its specific ligands, including epidermal growth factor and transforming growth factor α (TGFα) (note, a full list of the ligands able to activate EGFR and other members of the ErbB family is given in the ErbB article). ErbB2 has no known direct activating ligand, and may be in an activated state constitutively or become active upon heterodimerization with other family members such as EGFR. Upon activation by its growth factor ligands, EGFR undergoes a transition from an inactive monomeric form to an active homodimer – although there is some evidence that preformed inactive dimers may also exist before ligand binding. FGFR3 is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein would consist of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. Src (pronounced "sarc" as it is short for sarcoma) is a proto-oncogene encoding a tyrosine kinase originally discovered by J. Michael Bishop and Harold E. Varmus, for which they won the 1989 Nobel Prize in Physiology or Medicine. It belongs to a family of non-receptor tyrosine kinases called Src family kinases. The discovery of Src family proteins has been instrumental to the modern understanding of cancer as a disease where normally healthy cellular signalling has gone awry.